The Company will host a conference call and webcast at 8 am ET on Monday, September 22 to discuss the results from the Avail™ Phase 2 trial. Those who would like to participate may access the live ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback